OpenEvidence adds medication cost and coverage steps to the clinical workflow

What is changing?

OpenEvidence launched its Access Intelligence suite on November 11. According to the company's announcement distributed through Business Wire, the system addresses affordability and access issues that clinicians encounter after a treatment decision, within the same workflow. The tools answer questions about medication cost and coverage and show patient-support programs and steps that may lower out-of-pocket costs.

OpenEvidence says the suite is available today at no charge for clinicians, while the broader platform is free for verified U.S. clinicians. The announcement also describes a goal of reducing administrative work around support-program enrollment and prior authorization. Coverage, pricing, and eligibility can change, so results should still be checked against payer and program sources, and the tool should not replace clinical judgment.